Calderasib drug page Clinical trials

Trials with Calderasib

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

3Trials
2Recruiting
21Countries
1.457Planned patients

Showing 1–3 of 3

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Recruiting Phase 3 477 patients NCT06997497

Researchers are looking for other ways to treat locally advanced or metastatic colorectal cancer (mCRC) that is unresectable and has a gene mutation called KRAS G12C. Standard (or usual) treatments for this type of colorectal cancer may i…

United States, Argentina, Australia, Brazil and 7 more Jul 2025 – Oct 2030 Interventional
A Study of Calderasib (MK-1084) in KRAS Mutant Advanced Solid Tumors (MK-1084-001)
Recruiting Phase 1 830 patients NCT05067283

This is a study evaluating the safety, pharmacokinetics, and efficacy of calderasib alone, and calderasib plus other combination therapies in participants with advanced solid tumors with identified kirsten rat sarcoma viral oncogene homolo…

United States, Argentina, Australia, Canada and 7 more Dec 2021 – Feb 2030 Interventional
A Clinical Study of Calderasib (MK-1084) in People With Advanced Solid Tumors (MK-1084-014)
Ongoing, not recruiting Phase 2 150 patients NCT07209111

Researchers want to learn if calderasib given alone or with cetuximab can treat certain advanced solid tumors in people with the KRAS G12C mutation. The goals of this study are to learn: * How many people have the cancer respond (get sma…

United States, Australia, Chile, China and 8 more Dec 2025 – Apr 2032 Interventional
Combined with: Cetuximab

Where the recruiting trials are